Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. J Am Heart Assoc. 2023 07 04; 12(13):e028516.

View in: PubMed

subject areas

Blood Pressure
Canagliflozin
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Heart Failure
Humans
Kidney
Renal Insufficiency, Chronic

authors with profiles

George Bakris